Entradas de] Sanepsi

,

Nature Reviews Neuroscience was first published in October 2000. In this issue, we therefore mark the 20th anniversary of the journal.

Nature Reviews Neuroscience was launched in 2000 into an already burgeoning field, which has continued to flourish over the past 20 years. To capture some of the progress that has been made over the past two decades, and mark the journal’s anniversary, in this issue we feature a Viewpoint article in which some of the leading […]

,

Digital phenotyping and machine learning can help assess severe mental illness

Digital phenotyping approaches that collect and analyze Smartphone-user data on locations, activities, and even feelings – combined with machine learning to recognize patterns and make predictions from the data – have emerged as promising tools for monitoring patients with psychosis spectrum illnesses, according to a report in the September/October issue of Harvard Review of Psychiatry. The journal […]

Genetic discoveries show promise for developing new treatment targets for schizophrenia

In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia. These genetic discoveries raise the promise of developing urgently needed new treatments targeting the underlying biology and pathophysiology of schizophrenia, according to a special article in the Journal of Clinical Psychopharmacology. The journal is published in the Lippincott portfolio by […]

, ,

Depressive disorders in patients with HIV/AIDS often go unrecognized or untreated

People living with HIV/AIDS are at increased risk of depressive disorders. But all too often, these conditions go unrecognized or untreated, suggests a literature review in the May/June issue of Harvard Review of Psychiatry. The journal is published in the Lippincott portfolio by Wolters Kluwer. Proper diagnosis and management are essential to reduce negative health effects of […]